Medtronic announces cash dividend for second quarter of fiscal year 2023

(Neutral)

Rhea-AI Summary

Medtronic's board has approved a cash dividend of $0.68 per share for Q2 of fiscal year 2023, marking an 8% increase from the previous year. This dividend continues Medtronic's history as a member of the S&P 500 Dividend Aristocrats, having increased its dividend for 45 consecutive years. The dividend is set to be paid on October 14, 2022, to shareholders on record by September 23, 2022.

Positive

Approved $0.68 cash dividend per share for Q2 FY2023, an 8% increase from last year.
Maintains position in the S&P 500 Dividend Aristocrats index with 45 consecutive years of dividend increases.

Negative

None.

News Market Reaction – MDT

-0.25%

-0.25% Session move

In the trading session that priced this news, MDT declined 0.25%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/18/2022 - 04:30 PM

DUBLIN, Aug. 18, 2022 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 18, 2022, approved the fiscal year 2023 second quarter cash dividend of $0.68 per ordinary share, representing an 8% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May 2022. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 45 consecutive years. The dividend is payable on October 14, 2022, to shareholders of record at the close of business on September 23, 2022.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow @Medtronic on Twitter and LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:

Erika Winkels	Ryan Weispfenning
Public Relations	Investor Relations
+1-763-526-8478	+1-763-505-4626

View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-announces-cash-dividend-for-second-quarter-of-fiscal-year-2023-301608841.html

SOURCE Medtronic plc

FAQ

What is Medtronic's dividend for Q2 fiscal year 2023?

Medtronic announced a cash dividend of $0.68 per share for Q2 of fiscal year 2023.

When will Medtronic's Q2 dividend be paid?

The dividend will be payable on October 14, 2022, to shareholders of record as of September 23, 2022.

How much has Medtronic increased its dividend this year?

Medtronic has increased its dividend by 8% compared to the previous year.

For how many consecutive years has Medtronic increased its dividend?

Medtronic has increased its dividend for 45 consecutive years.

Is Medtronic part of any significant stock index?

Yes, Medtronic is part of the S&P 500 Dividend Aristocrats index.